SCHEMBL4837779

SCHEMBL4837779

CC(C)(C)COCc1ccco1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
MAPT P10636 6/20 0.44
CYP2D6 P10635 1/20 0.44
GAA P10253 3/20 0.43
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 2/20 0.38
RIPK1 Q13546 1/20 0.37
POLB P06746 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
MAPK1 P28482 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25423021 0.81 ALDH1A1 (0.46) ALDH1A1MAPTCYP2D6GAAKDM4E
SCHEMBL891457 0.81 ALDH1A1 (0.55) ALDH1A1MAPTCYP2D6GAAKDM4E
SCHEMBL796696 0.81 ALDH1A1 (0.44) ALDH1A1MAPTCYP2D6GAAKDM4E
SCHEMBL10485701 0.79 ALDH1A1 (0.53) ALDH1A1MAPTCYP2D6GAAKDM4E
SCHEMBL25425192 0.78 ALDH1A1 (0.42) ALDH1A1MAPTCYP2D6GAAKDM4E
SCHEMBL1152092 0.78
SCHEMBL15087211 0.77 ALDH1A1 (0.52) ALDH1A1MAPTCYP2D6GAAKDM4E
SCHEMBL18556304 0.76 ALDH1A1 (0.39) ALDH1A1MAPTCYP2D6GAAHTT
Water SCHEMBL11881132 0.76 ALDH1A1 (0.52) ALDH1A1MAPTCYP2D6GAAKDM4E
SCHEMBL44854 0.76 ALDH1A1 (0.52) ALDH1A1MAPTCYP2D6GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7399697-B2 Very low dielectric constant plasma-enhanced CVD films APPLIED MATERIALS, INC. (US) 2008-07-15 US claimed
US-20050136240-A1 Very low dielectric constant plasma-enhanced CVD films MANDAL ROBERT P (US) 2005-06-23 US claimed
US-20020142585-A1 Very low dielectric constant plasma-enhanced CVD films APPLIED MATERIALS, INC. 2002-10-03 US claimed
US-10662211-B2 Catalysts and methods for polymer synthesis Saurdi Aramco Technologies Company (SA) 2020-05-26 US disclosed
US-20180179242-A1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS NOVOMER, INC. 2018-06-28 US disclosed
US-20180179242-A1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS NOVOMER, INC. 2018-06-28 US disclosed
US-9951096-B2 Catalysts and methods for polymer synthesis SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2018-04-24 US disclosed
US-9951096-B2 Catalysts and methods for polymer synthesis SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2018-04-24 US disclosed
US-9856349-B2 Catalysts and methods for polymer synthesis SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2018-01-02 US disclosed
US-20170183369-A1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-06-29 US disclosed
US-20170183369-A1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-06-29 US disclosed
US-7915255-B2 Metabolism-modulating agents and uses therefor VERVA PHARMACEUTICALS PTY LTD (AU) 2011-03-29 US disclosed
US-20100144969-A1 ISOSELECTIVE POLYMERIZATION OF EPOXIDES CORNELL UNIVERSITY (US) 2010-06-10 US disclosed
US-20090030051-A1 Inhibitors of IMPDH enzyme VERTEX PHARMACEUTICALS INCORPORATED 2009-01-29 US disclosed
US-20090030051-A1 Inhibitors of IMPDH enzyme VERTEX PHARMACEUTICALS INCORPORATED 2009-01-29 US disclosed
US-7432290-B2 Inhibitors of IMPDH enzyme VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-10-07 US disclosed
US-7399697-B2 Very low dielectric constant plasma-enhanced CVD films APPLIED MATERIALS, INC. (US) 2008-07-15 US disclosed
US-20050136240-A1 Very low dielectric constant plasma-enhanced CVD films MANDAL ROBERT P (US) 2005-06-23 US disclosed
US-6890639-B2 Very low dielectric constant plasma-enhanced CVD films APPLIED MATERIALS, INC. (US) 2005-05-10 US disclosed
US-20020142585-A1 Very low dielectric constant plasma-enhanced CVD films APPLIED MATERIALS, INC. 2002-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144969-A1 ISOSELECTIVE POLYMERIZATION OF EPOXIDES EPHX2, EPHX1, GNE ALDH1A1 155/4885MAPT 3160/4885CYP2D6 247/4885
US-10662211-B2 Catalysts and methods for polymer synthesis PPOX, COASY, SOD1 ALDH1A1 2255/4885MAPT 3940/4885CYP2D6 690/4885
US-20180179242-A1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS PPOX, COASY, SOD1 ALDH1A1 2255/4885MAPT 3940/4885CYP2D6 690/4885
US-20090030051-A1 Inhibitors of IMPDH enzyme IMPDH1, IMPDH2, IMPA1 ALDH1A1 38/4885MAPT 2491/4885CYP2D6 290/4885
US-20170183369-A1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS PPOX, COASY, SOD1 ALDH1A1 2255/4885MAPT 3940/4885CYP2D6 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.